Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
Université Paris-Sud · Inserm · +11 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
857
total citations
- FWCI
- 40.84
- Percentile
- 100%
- References
- 170
Citations per year
Authors
4- LZLaurence Zitvogel
Université Paris-Sud, Inserm, Université Paris-Saclay, Institut Gustave Roussy
- LGLorenzo Galluzzi
Délégation Paris 5, Université Paris Cité, Sorbonne Paris Cité, Centre de Recherche des Cordeliers
- MJMark J. Smyth
The University of Queensland, QIMR Berghofer Medical Research Institute
- GKGuido KroemerCorresponding
Délégation Paris 5, Inserm, Université Paris Cité, Institut Gustave Roussy, Sorbonne Paris Cité, Centre de Recherche des Cordeliers, Assistance Publique – Hôpitaux de Paris, Hôpital Européen Georges-Pompidou, Hôpital Européen
Topics & keywords
Topics
Keywords
- Immunosurveillance
- Immune system
- Biology
- Effector
- Cancer
- Epigenetics
- Immunology
- Immunotherapy
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.